BAKER BROS. ADVISORS LP

Holdings History for Neurogene Inc. - Common Stock, $0.000001 par value (NGNE)

Symbol: NGNE on Nasdaq
Investment type: Equity / Common Stock, $0.000001 par value
Latest Disclosed Shares Owned: 991,804 shares
Security Ownership %: 7%

Shares, Excluding Options vs Price

Value, Excluding Options

Julian C. Baker ownership in Neurogene Inc. Common Stock, $0.000001 par value (NGNE)

14 Aug 2025 - Julian C. Baker has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 991,804 shares of Neurogene Inc. Common Stock, $0.000001 par value (NGNE). This represents 7% ownership of the company. In their previous filing dated 15 May 2025, BAKER BROS. ADVISORS LP had reported owning 1,486,313 shares, indicating a decrease of +33%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Julian C. Baker	7%	-30%	$21,254,360	991,804	-494,509	-33%	$21.43	13G/A	30 Jun 2025	14 Aug 2025, 16:27
Julian C. Baker	10%		$22,904,083	1,486,313			$15.41	13G	31 Mar 2025	15 May 2025, 16:19

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.12%	0%	$20,428,835	991,691	0		$20.60	Q4 2025
30 Sep 2025	0.12%	0%	$17,186,005	991,691	0		$17.33	Q3 2025
30 Jun 2025	0.14%	-0.07%	$14,825,780	991,691	-494,509	-33%	$14.95	Q2 2025
31 Mar 2025	0.19%	+0.11%	$17,403,402	1,486,200	+811,750	+100%	$11.71	Q1 2025
31 Dec 2024	0.16%	+0.05%	$15,417,927	674,450	+218,435	+48%	$22.86	Q4 2024
30 Sep 2024	0.2%	0%	$19,134,389	456,015	0		$41.96	Q3 2024
30 Jun 2024	0.21%	0%	$16,594,386	456,015	0		$36.39	Q2 2024
31 Mar 2024	0.29%	+0%	$23,211,164	456,015	+2,499	+0.55%	$50.90	Q1 2024
31 Dec 2023	0.1%	+0.1%	$8,789,140	453,516	+453,516	NEW	$19.38	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.